Revolution Medicines, Inc. is 14.8x more valuable than BIOCRYST PHARMACEUTICALS INC by market capitalization ($30.74 B vs $2.08 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | BCRX | RVMD |
|---|---|---|
| Market cap | $2.08 B | $30.74 B |
| US-listed rank | #2072 | #453 |
| Revenue (latest FY) | $874.84M | $0.00 |
| Net income (latest FY) | $263.86M | -$1.13B |
| Net margin | 30.2% | - |
| P/E (trailing FY) | 7.9 | - |
| SEC filings | 1,935 | 782 |
Revolution Medicines, Inc. is 14.8x more valuable than BIOCRYST PHARMACEUTICALS INC by market capitalization ($30.74 B vs $2.08 B).
In their latest fiscal years, BIOCRYST PHARMACEUTICALS INC reported $874.84M in revenue while Revolution Medicines, Inc. reported $0.00.
Full pages: BIOCRYST PHARMACEUTICALS INC and Revolution Medicines, Inc., or browse the full rankings.